Statement of preliminary issues published for CDC Pharmaceutical and Pharmacy Wholesalers merger
11 July 2014
The Commerce Commission has published a statement of preliminary issues relating to a joint application from CDC
Pharmaceuticals Limited and Pharmacy Wholesalers (Central) Limited (PWL Central) seeking clearance to merge their
respective wholesaling pharmaceutical businesses.
The statement of preliminary issues outlines the key competition issues that the Commission currently considers will be
important in deciding whether or not to grant clearance. The Commission’s statement of preliminary issues and the public
version of the application are available on the Clearances Register.
The Commission invites submissions from parties who consider that they have information relevant to the Commission’s
consideration of this matter. Submissions can be sent to registrar@comcom.govt.nz with the reference CDC/PWL Central in the subject line of your email or to PO Box 2351, Wellington 6140 by close of
business Friday 18 July 2104
You can find the statement of preliminary issues on the Clearances Register.
Background
Both CDC and PWL Central wholesale prescription, specialist hospital only, and over the counter pharmaceutical products
to pharmacies and hospitals.
Currently, CDC primarily supplies pharmaceuticals in the South Island and in Wellington while PWL Central primarily
supplies pharmaceuticals in the central North Island.
Both parties also have a presence in Auckland.
ENDS